Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles
Abstract Chemotherapeutic agents have limited efficacy and resistance to them limits today and will limit tomorrow our capabilities of cure. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic difference...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Cancer Nanotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12645-017-0030-4 |